Skip to main content
. Author manuscript; available in PMC: 2019 Dec 26.
Published in final edited form as: J Neurooncol. 2018 Jun 16;140(1):55–62. doi: 10.1007/s11060-018-2930-5

Fig. 1.

Fig. 1

Kaplan-meier analysis of a patient-based local control, b lesion-based local control, c out of field central nervous system (CNS) progression, d extra-CNS (eCNS) progression, e progression-free survival, and f overall survival, for patients receiving immune checkpoint inhibitors within 8 weeks of stereotactic radiosurgery